Armata Pharmaceuticals's total assets for Q1 2026 were $69.80M, a decrease of -9.21% from the previous quarter. ARMP total liabilities were $381.39M for the fiscal quarter, a 29.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.